Evidence-based guideline: IV immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Li, Hai-feng; Gao, Xiang; Hong, Yu; Patwa, Huned S; Chaudhry, Vinay; Rae-Grant, Alex D; So, Yuen T; Alto, Palo

Li, Hai-feng; Gao, Xiang; Hong, Yu; Patwa, Huned S; Chaudhry, Vinay; Rae-Grant, Alex D; So, Yuen T; Alto, Palo.

Neurology ; 79(13): 1411; author reply 1411, 2012 Sep 25.

Article in En | MEDLINE | ID: mdl-23008223

Subject(s)

Evidence-Based Medicine/standards; Immunoglobulins, Intravenous/administration & dosage; Neurology/standards; Neuromuscular Diseases/drug therapy; Technology Assessment, Biomedical/standards; Humans

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Technology Assessment, Biomedical / Immunoglobulins, Intravenous / Evidence-Based Medicine / Neurology / Neuromuscular Diseases Type of study: Guideline / Health_technology_assessment Limits: Humans Language: En Journal: Neurology Year: 2012 Document type: Article Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links